Cytokines as tumor markers in breast cancer
Ławicki, S.ła.; Mroczko, B.; Szmitkowski, M.
Postepy Higieny i Medycyny Doswiadczalnej 57(4): 455-463
2003
ISSN/ISBN: 0032-5449 PMID: 14626202 Document Number: 558625
Serum tumour markers may be helpful in early diagnosis of breast cancer, in the initial assessment of the extent of the disease, and in monitoring of the tumor growth or tumor volume reduction. Recent studies have focused the role of cytokines as a new group of tumour markers for breast cancer.
Document emailed within 1 workday
Related Documents
Inaji, H.; Komoike, Y.; Motomura, K.; Koyama, H. 2000: Tumor markers in breast cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 58 Suppl: 140-145Jotti, G.S.; Bombardieri, E. 1990: Circulating tumor markers in breast cancer (review) Anticancer Research 10(1): 253-258
Mangkharak, J.; Patanachak, C.; Podhisuwan, K.; Pleehachinda, R. 1997: The evaluation of combined scintimammography and tumor markers in breast cancer patients Anticancer Research 17(3B): 1611-1614
Nozawa, S.; Udagawa, Y.; Sasaki, H.; Ito, K.; Akiya, K.; Terashima, Y.; Takamizawa, H.; Ohkura, H.; Fujimoto, S.; Hashimoto, M. 1992: Studies of clinical usefulness of new tumor markers of ovarian cancer, CA 54/61 and CA 602--CA 602 assay reagent kit, performance its normal value and correlations with other tumor markers Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(12): 2085-2093
Hou, J.-X.; Yang, X.-Q.; Chen, C.; Jiang, Q.; Yang, G.-L.; Li, Y. 2011: Screening the gastric cancer related tumor markers from multi-tumor markers protein chip with kappa coefficient and cost-effectiveness analysis Hepato-Gastroenterology 58(106): 632-636
Schuurman, J.J.; Bong, S.B.; Einarsson, R. 1996: Determination of serum tumor markers TPS and CA 15-3 during monitoring of treatment in metastatic breast cancer patients Anticancer Research 16(4b): 2169-2172
Xing, Y.; Zhao, J.-h.; Wang, T.-s.; Qiao, W.-l.; Che, W.-j. 2009: The role of 18F-FDG SPECT-CT in detecting recurrence and metastases in breast cancer patients with elevated tumor markers Zhonghua Zhong Liu Za Zhi 31(2): 129-133
Zissimopoulos, A.; Matthaios, D.; Matthaiou, E.; Mantadakis, E.; Karaitianos, I. 2007: Association between bone scintigraphy and serum levels of tumor markers in the detection of bone disease in breast cancer patients Journal of BUON: Official Journal of the Balkan Union of Oncology 12(4): 505-511
Koda, M.; Kanczuga-Koda, L.; Reszec, J.; Sulkowska, M.; Famulski, W.; Baltaziak, M.; Kisielewski, W.; Sulkowski, S. 2004: Expression of the apoptotic markers in normal breast epithelium, benign mammary dysplasia and in breast cancer Folia Morphologica 63(3): 337-341
Crombach, G. 1998: Considerations in rational use of tumor markers in breast carcinoma Praxis 87(17): 589-594
Yokoe, T.; Iino, Y.; Takei, H.; Horiguchi, J.; Koibuchi, Y.; Maemura, M.; Ohwada, S.; Morishita, Y. 1997: Changes of cytokines and thyroid function in patients with recurrent breast cancer Anticancer Research 17(1b): 695-699
Larsen, C.; Zachariae, C.; Mukaida, N.; Anderson, A.; Yamada, M.; Oppenheim, J.; Matsushima, K. 1990: Proinflammatory cytokines interleukin 1 and tumor necrosis factor induce cytokines that are chemotactic for neutrophils, T cells and monocytes Progress in Clinical and Biological Research 349: 419-431
Thomas, C.M.; Wobbes, T.; Bonfrer, J.M.; Peterse, J.L.; Nap, M.; Beex, L.V. 1993: Tumor markers in screening, diagnosis and treatment of patients with breast carcinoma Nederlands Tijdschrift Voor Geneeskunde 137(46): 2354-2357
Bellet, D.; Mlika-Cabanne, N.; Bedenne, L.; Brun, B.; Demeaux, J.L.; Legrand, J.L.; Lorimier, G.; Mignotte, H.; Ollivier, J.M.; Piperno-Neumann, S.; Rinaldi, Y.; Rousset, H.; Rymer, J.C.; Laversin, S. 2001: Serum markers in breast cancer and colorectal cancer (1997) Gynecologie Obstetrique and Fertilite 29(1): 62-63
Yamauchi, M.; Yoshigoe, F.; Mera, F.; Ogura, K.; Kameda, H.; Nakada, J.; Takasaka, S.; Machida, T.; Fukunaga, M. 1983: An autopsy case of double cancer (Hepatocellular carcinoma and mixed germ cell tumor of the testis)--significance of alpha-fetoprotein and human chorionic gonadotropin as tumor markers Gan no Rinsho. Japan Journal of Cancer Clinics 29(4): a
Gelin, J.; Andersson, C.; Lundholm, K. 1991: Effects of indomethacin, cytokines, and cyclosporin A on tumor growth and the subsequent development of cancer cachexia Cancer Research 51(3): 880-885
Pluygers, E.P.; Beauduin, M.P.; Baldewyns, P.E.; Burion, J.A. 1986: Tumor markers for cancer detection. Ii Cancer Detection and Prevention 9(5-6): 505-509
Gorgone, S.; Alleruzzo, A.; Rizzo, A.G.; Labruto, G.; Di Pietro, N.; Sampiero, G.; Barbuscia, M.; Arsena, A. 1992: Tumor markers in colorectal cancer Minerva Chirurgica 47(15-16): 1249-1252
Ritter, J. 1987: Tumor markers in cancer of the ovary Journal de Gynecologie Obstetrique et Biologie de la Reproduction 16(8): 1086-1087
Putzki, H.; Reichert, B.; Jablonski, M.; Heymann, H. 1988: The tumor markers CEA, TPA and CA 19-9 in gastric cancer Deutsche Zeitschrift für Verdauungs- und Stoffwechselkrankheiten 48(3-4): 145-148